SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1B2'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1NYR_A_THRA1004_0 (THREONYL-TRNASYNTHETASE 1) |
4hwt | THREONINE--TRNALIGASE, CYTOPLASMIC (Homosapiens) | 8 / 10 | MET A 444CYH A 446ARG A 475ASP A 495HIS A 497TYR A 573GLN A 595HIS A 623 | 1B2 A 802 (-2.6A) ZN A 801 ( 2.3A)1B2 A 802 (-2.5A)1B2 A 802 (-3.6A) ZN A 801 ( 3.3A)None1B2 A 802 (-3.3A) ZN A 801 ( 3.1A) | 0.29A | 1nyrA-4hwtA:49.3 | 1nyrA-4hwtA:25.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1NYR_B_THRB2004_0 (THREONYL-TRNASYNTHETASE 1) |
4hwt | THREONINE--TRNALIGASE, CYTOPLASMIC (Homosapiens) | 8 / 10 | MET A 444CYH A 446ARG A 475ASP A 495HIS A 497TYR A 573GLN A 595HIS A 623 | 1B2 A 802 (-2.6A) ZN A 801 ( 2.3A)1B2 A 802 (-2.5A)1B2 A 802 (-3.6A) ZN A 801 ( 3.3A)None1B2 A 802 (-3.3A) ZN A 801 ( 3.1A) | 0.71A | 1nyrB-4hwtA:47.9 | 1nyrB-4hwtA:25.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_A_TFPA202_1 (PROTEIN S100-A4) |
4hwt | THREONINE--TRNALIGASE, CYTOPLASMIC (Homosapiens) | 5 / 12 | LEU A 596ILE A 509CYH A 512PHE A 515ASP A 495 | NoneNoneNoneNone1B2 A 802 (-3.6A) | 1.22A | 3ko0A-4hwtA:1.23ko0B-4hwtA:1.23ko0C-4hwtA:1.13ko0D-4hwtA:1.1 | 3ko0A-4hwtA:14.493ko0B-4hwtA:14.493ko0C-4hwtA:14.493ko0D-4hwtA:14.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_C_TFPC202_1 (PROTEIN S100-A4) |
4hwt | THREONINE--TRNALIGASE, CYTOPLASMIC (Homosapiens) | 5 / 11 | ASP A 495LEU A 596ILE A 509CYH A 512PHE A 515 | 1B2 A 802 (-3.6A)NoneNoneNoneNone | 1.24A | 3ko0A-4hwtA:1.23ko0B-4hwtA:1.23ko0C-4hwtA:1.13ko0D-4hwtA:1.1 | 3ko0A-4hwtA:14.493ko0B-4hwtA:14.493ko0C-4hwtA:14.493ko0D-4hwtA:14.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_D_TFPD202_1 (PROTEIN S100-A4) |
4hwt | THREONINE--TRNALIGASE, CYTOPLASMIC (Homosapiens) | 5 / 11 | LEU A 596ILE A 509CYH A 512PHE A 515ASP A 495 | NoneNoneNoneNone1B2 A 802 (-3.6A) | 1.24A | 3ko0C-4hwtA:1.13ko0D-4hwtA:1.13ko0E-4hwtA:1.13ko0F-4hwtA:0.9 | 3ko0C-4hwtA:14.493ko0D-4hwtA:14.493ko0E-4hwtA:14.493ko0F-4hwtA:14.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_E_TFPE202_1 (PROTEIN S100-A4) |
4hwt | THREONINE--TRNALIGASE, CYTOPLASMIC (Homosapiens) | 5 / 11 | ASP A 495LEU A 596ILE A 509CYH A 512PHE A 515 | 1B2 A 802 (-3.6A)NoneNoneNoneNone | 1.20A | 3ko0C-4hwtA:1.13ko0D-4hwtA:1.13ko0E-4hwtA:1.13ko0F-4hwtA:0.9 | 3ko0C-4hwtA:14.493ko0D-4hwtA:14.493ko0E-4hwtA:14.493ko0F-4hwtA:14.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_F_TFPF202_1 (PROTEIN S100-A4) |
4hwt | THREONINE--TRNALIGASE, CYTOPLASMIC (Homosapiens) | 5 / 11 | LEU A 596ILE A 509CYH A 512PHE A 515ASP A 495 | NoneNoneNoneNone1B2 A 802 (-3.6A) | 1.26A | 3ko0E-4hwtA:1.13ko0F-4hwtA:0.93ko0G-4hwtA:0.83ko0H-4hwtA:1.0 | 3ko0E-4hwtA:14.493ko0F-4hwtA:14.493ko0G-4hwtA:14.493ko0H-4hwtA:14.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_H_TFPH202_1 (PROTEIN S100-A4) |
4hwt | THREONINE--TRNALIGASE, CYTOPLASMIC (Homosapiens) | 5 / 12 | LEU A 596ILE A 509CYH A 512PHE A 515ASP A 495 | NoneNoneNoneNone1B2 A 802 (-3.6A) | 1.24A | 3ko0G-4hwtA:0.83ko0H-4hwtA:1.03ko0I-4hwtA:1.13ko0J-4hwtA:1.1 | 3ko0G-4hwtA:14.493ko0H-4hwtA:14.493ko0I-4hwtA:14.493ko0J-4hwtA:14.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_I_TFPI202_1 (PROTEIN S100-A4) |
4hwt | THREONINE--TRNALIGASE, CYTOPLASMIC (Homosapiens) | 5 / 12 | ASP A 495LEU A 596ILE A 509CYH A 512PHE A 515 | 1B2 A 802 (-3.6A)NoneNoneNoneNone | 1.27A | 3ko0G-4hwtA:0.83ko0H-4hwtA:1.03ko0I-4hwtA:1.13ko0J-4hwtA:1.1 | 3ko0G-4hwtA:14.493ko0H-4hwtA:14.493ko0I-4hwtA:14.493ko0J-4hwtA:14.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_J_TFPJ202_1 (PROTEIN S100-A4) |
4hwt | THREONINE--TRNALIGASE, CYTOPLASMIC (Homosapiens) | 5 / 11 | ASP A 495LEU A 596ILE A 509CYH A 512PHE A 515 | 1B2 A 802 (-3.6A)NoneNoneNoneNone | 1.21A | 3ko0A-4hwtA:1.13ko0B-4hwtA:1.23ko0I-4hwtA:1.13ko0J-4hwtA:1.0 | 3ko0A-4hwtA:14.493ko0B-4hwtA:14.493ko0I-4hwtA:14.493ko0J-4hwtA:14.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_L_TFPL202_1 (PROTEIN S100-A4) |
4hwt | THREONINE--TRNALIGASE, CYTOPLASMIC (Homosapiens) | 5 / 12 | LEU A 596ILE A 509CYH A 512PHE A 515ASP A 495 | NoneNoneNoneNone1B2 A 802 (-3.6A) | 1.23A | 3ko0K-4hwtA:0.93ko0L-4hwtA:1.03ko0M-4hwtA:1.13ko0N-4hwtA:1.1 | 3ko0K-4hwtA:14.493ko0L-4hwtA:14.493ko0M-4hwtA:14.493ko0N-4hwtA:14.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_M_TFPM202_1 (PROTEIN S100-A4) |
4hwt | THREONINE--TRNALIGASE, CYTOPLASMIC (Homosapiens) | 5 / 12 | LEU A 596ILE A 509CYH A 512PHE A 515ASP A 495 | NoneNoneNoneNone1B2 A 802 (-3.6A) | 1.22A | 3ko0M-4hwtA:1.13ko0N-4hwtA:1.13ko0O-4hwtA:1.03ko0P-4hwtA:0.8 | 3ko0M-4hwtA:14.493ko0N-4hwtA:14.493ko0O-4hwtA:14.493ko0P-4hwtA:14.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_N_TFPN202_1 (PROTEIN S100-A4) |
4hwt | THREONINE--TRNALIGASE, CYTOPLASMIC (Homosapiens) | 5 / 11 | ASP A 495LEU A 596ILE A 509CYH A 512PHE A 515 | 1B2 A 802 (-3.6A)NoneNoneNoneNone | 1.24A | 3ko0K-4hwtA:0.93ko0L-4hwtA:1.13ko0M-4hwtA:1.13ko0N-4hwtA:1.1 | 3ko0K-4hwtA:14.493ko0L-4hwtA:14.493ko0M-4hwtA:14.493ko0N-4hwtA:14.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_O_TFPO202_1 (PROTEIN S100-A4) |
4hwt | THREONINE--TRNALIGASE, CYTOPLASMIC (Homosapiens) | 5 / 11 | LEU A 596ILE A 509CYH A 512PHE A 515ASP A 495 | NoneNoneNoneNone1B2 A 802 (-3.6A) | 1.23A | 3ko0O-4hwtA:1.03ko0P-4hwtA:0.93ko0Q-4hwtA:undetectable3ko0R-4hwtA:1.1 | 3ko0O-4hwtA:14.493ko0P-4hwtA:14.493ko0Q-4hwtA:14.493ko0R-4hwtA:14.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_P_TFPP202_1 (PROTEIN S100-A4) |
4hwt | THREONINE--TRNALIGASE, CYTOPLASMIC (Homosapiens) | 5 / 12 | ASP A 495LEU A 596ILE A 509CYH A 512PHE A 515 | 1B2 A 802 (-3.6A)NoneNoneNoneNone | 1.18A | 3ko0M-4hwtA:1.13ko0N-4hwtA:1.13ko0O-4hwtA:1.03ko0P-4hwtA:0.9 | 3ko0M-4hwtA:14.493ko0N-4hwtA:14.493ko0O-4hwtA:14.493ko0P-4hwtA:14.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_Q_TFPQ202_1 (PROTEIN S100-A4) |
4hwt | THREONINE--TRNALIGASE, CYTOPLASMIC (Homosapiens) | 5 / 10 | ASP A 495LEU A 596ILE A 509CYH A 512PHE A 515 | 1B2 A 802 (-3.6A)NoneNoneNoneNone | 1.23A | 3ko0O-4hwtA:1.03ko0P-4hwtA:0.93ko0Q-4hwtA:0.23ko0R-4hwtA:1.1 | 3ko0O-4hwtA:14.493ko0P-4hwtA:14.493ko0Q-4hwtA:14.493ko0R-4hwtA:14.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_T_TFPT202_1 (PROTEIN S100-A4) |
4hwt | THREONINE--TRNALIGASE, CYTOPLASMIC (Homosapiens) | 5 / 11 | ASP A 495LEU A 596ILE A 509CYH A 512PHE A 515 | 1B2 A 802 (-3.6A)NoneNoneNoneNone | 1.22A | 3ko0Q-4hwtA:undetectable3ko0R-4hwtA:1.13ko0S-4hwtA:1.03ko0T-4hwtA:1.1 | 3ko0Q-4hwtA:14.493ko0R-4hwtA:14.493ko0S-4hwtA:14.493ko0T-4hwtA:14.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K87_A_ADNA602_1 (PROLINE--TRNA LIGASE) |
4hwt | THREONINE--TRNALIGASE, CYTOPLASMIC (Homosapiens) | 4 / 8 | ARG A 475PHE A 491THR A 593ARG A 632 | 1B2 A 802 (-2.5A)None1B2 A 802 ( 4.1A)None | 0.69A | 4k87A-4hwtA:26.0 | 4k87A-4hwtA:22.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4U8Y_B_MIYB1102_1 (MULTIDRUG EFFLUXPUMP SUBUNIT ACRB) |
4hwt | THREONINE--TRNALIGASE, CYTOPLASMIC (Homosapiens) | 5 / 12 | PHE A 559GLU A 564ASN A 530ASP A 578ILE A 577 | NoneNoneNone1B2 A 802 (-3.7A)None | 1.14A | 4u8yB-4hwtA:undetectable | 4u8yB-4hwtA:18.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4U95_B_MIYB1102_1 (MULTIDRUG EFFLUXPUMP SUBUNIT ACRB) |
4hwt | THREONINE--TRNALIGASE, CYTOPLASMIC (Homosapiens) | 5 / 12 | PHE A 559GLU A 564ASN A 530ASP A 578ILE A 577 | NoneNoneNone1B2 A 802 (-3.7A)None | 1.10A | 4u95B-4hwtA:undetectable | 4u95B-4hwtA:17.95 |